Replies to post #11654 on Sorrento Therapeutics Inc (SRNE)

[Logon26]

„ If positive, we plan to request a meeting with the US Food and Drug Administration (FDA) by the first half of 2022 to negotiate NDA filing," commented Dr. Dmitri Lissin MD, Chief Medical Officer of Scilex Holding Company.“

That’s a bit a long way to wait…